RegenRx Release: New Data on Thymosin Beta 4 Reported at Third International Symposium on Thymosins in Health and Disease
Published: Mar 20, 2012
ROCKVILLE, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) (“the Company” or “RegeneRx”) today reported on data presented at the Third International Symposium on Thymosins in Health and Disease in Washington, D.C. Full papers from the three- day symposium will be published in the Annals of the New York Academy of Sciences later this year. The first day of the symposium included a keynote talk by Dr. Deepak Srivastava, Director of the Gladstone Cardiovascular Institute at the University of California, San Francisco, on the reprogramming of cardiac cells by Tß4. The second day of the symposium focused on basic research while the third day focused primarily on clinical and in vivo results.